Antidepressant treatment of cytokine-induced mood disorders

Charles L Raison, Michael Marcin, Andrew H. Miller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Significant evidence suggests that the immune system is capable of profoundly affecting central nervous system (CNS) functioning in ways that may contribute to the development and expression of neuropsychiatric disorders, including disorders of mood. This paper reviews evidence that the production of proinflammatory cytokines, whether in the context of therapeutic administration (e.g. interferonα-2b for hepatitis C infection) or medical illness, induces a state of sickness behavior that closely resembles major depression. Antidepressants have been shown to abolish or attenuate cytokineinduced sickness behavior in laboratory animals and to protect against the development of major depression in the context of therapeutic cytokine administration in humans. Potential mechanisms by which antidepressants ameliorate depressive and/or sickness symptoms in the context of immune activation include direct effects on immune cell functioning, as well as modulatory effects on monoamine neurotransmitters, intracellular second messenger pathways and the neuroendocrine system, in particular the hypothalamic - pituitary - adrenal axis.

Original languageEnglish (US)
Pages (from-to)336-343
Number of pages8
JournalActa Neuropsychiatrica
Volume14
Issue number6
DOIs
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Illness Behavior
Mood Disorders
Antidepressive Agents
Depression
Cytokines
Neurosecretory Systems
Laboratory Animals
Second Messenger Systems
Hepatitis C
Interferons
Neurotransmitter Agents
Immune System
Central Nervous System
Therapeutics
Infection

Keywords

  • Antidepressant
  • Cytokines
  • Immune
  • Mood disorders

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Antidepressant treatment of cytokine-induced mood disorders. / Raison, Charles L; Marcin, Michael; Miller, Andrew H.

In: Acta Neuropsychiatrica, Vol. 14, No. 6, 12.2002, p. 336-343.

Research output: Contribution to journalArticle

Raison, Charles L ; Marcin, Michael ; Miller, Andrew H. / Antidepressant treatment of cytokine-induced mood disorders. In: Acta Neuropsychiatrica. 2002 ; Vol. 14, No. 6. pp. 336-343.
@article{36963ed5cca44f3f9c31e38aa57ddd15,
title = "Antidepressant treatment of cytokine-induced mood disorders",
abstract = "Significant evidence suggests that the immune system is capable of profoundly affecting central nervous system (CNS) functioning in ways that may contribute to the development and expression of neuropsychiatric disorders, including disorders of mood. This paper reviews evidence that the production of proinflammatory cytokines, whether in the context of therapeutic administration (e.g. interferonα-2b for hepatitis C infection) or medical illness, induces a state of sickness behavior that closely resembles major depression. Antidepressants have been shown to abolish or attenuate cytokineinduced sickness behavior in laboratory animals and to protect against the development of major depression in the context of therapeutic cytokine administration in humans. Potential mechanisms by which antidepressants ameliorate depressive and/or sickness symptoms in the context of immune activation include direct effects on immune cell functioning, as well as modulatory effects on monoamine neurotransmitters, intracellular second messenger pathways and the neuroendocrine system, in particular the hypothalamic - pituitary - adrenal axis.",
keywords = "Antidepressant, Cytokines, Immune, Mood disorders",
author = "Raison, {Charles L} and Michael Marcin and Miller, {Andrew H.}",
year = "2002",
month = "12",
doi = "10.1034/j.1601-5215.2002.140607.x",
language = "English (US)",
volume = "14",
pages = "336--343",
journal = "Acta Neuropsychiatrica",
issn = "0924-2708",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Antidepressant treatment of cytokine-induced mood disorders

AU - Raison, Charles L

AU - Marcin, Michael

AU - Miller, Andrew H.

PY - 2002/12

Y1 - 2002/12

N2 - Significant evidence suggests that the immune system is capable of profoundly affecting central nervous system (CNS) functioning in ways that may contribute to the development and expression of neuropsychiatric disorders, including disorders of mood. This paper reviews evidence that the production of proinflammatory cytokines, whether in the context of therapeutic administration (e.g. interferonα-2b for hepatitis C infection) or medical illness, induces a state of sickness behavior that closely resembles major depression. Antidepressants have been shown to abolish or attenuate cytokineinduced sickness behavior in laboratory animals and to protect against the development of major depression in the context of therapeutic cytokine administration in humans. Potential mechanisms by which antidepressants ameliorate depressive and/or sickness symptoms in the context of immune activation include direct effects on immune cell functioning, as well as modulatory effects on monoamine neurotransmitters, intracellular second messenger pathways and the neuroendocrine system, in particular the hypothalamic - pituitary - adrenal axis.

AB - Significant evidence suggests that the immune system is capable of profoundly affecting central nervous system (CNS) functioning in ways that may contribute to the development and expression of neuropsychiatric disorders, including disorders of mood. This paper reviews evidence that the production of proinflammatory cytokines, whether in the context of therapeutic administration (e.g. interferonα-2b for hepatitis C infection) or medical illness, induces a state of sickness behavior that closely resembles major depression. Antidepressants have been shown to abolish or attenuate cytokineinduced sickness behavior in laboratory animals and to protect against the development of major depression in the context of therapeutic cytokine administration in humans. Potential mechanisms by which antidepressants ameliorate depressive and/or sickness symptoms in the context of immune activation include direct effects on immune cell functioning, as well as modulatory effects on monoamine neurotransmitters, intracellular second messenger pathways and the neuroendocrine system, in particular the hypothalamic - pituitary - adrenal axis.

KW - Antidepressant

KW - Cytokines

KW - Immune

KW - Mood disorders

UR - http://www.scopus.com/inward/record.url?scp=0036908624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036908624&partnerID=8YFLogxK

U2 - 10.1034/j.1601-5215.2002.140607.x

DO - 10.1034/j.1601-5215.2002.140607.x

M3 - Article

AN - SCOPUS:0036908624

VL - 14

SP - 336

EP - 343

JO - Acta Neuropsychiatrica

JF - Acta Neuropsychiatrica

SN - 0924-2708

IS - 6

ER -